Neuland Laboratories Ltd.

Financial

	Neuland Laboratories	Gufic Biosciences	Alivus Life Sciences
Operational Metrics
Pharmaceutical Sector
US DMF Filings	72.0 .	n/a	561.0 .
Global DMFs filed	993.0 .	n/a	n/a
Total reactor capacity	1174.0 kL	n/a	n/a
R&D as a % of Total Sales	4.15 %	0.83 %	3.4 %
Financials
5 yr Average ROE	14.95 %	25.05 %	37.41 %
5yr average Equity Multiplier	1.56	2.22	2.33
5yr Average Asset Turnover Ratio	0.74	1.05	0.76
5yr Avg Net Profit Margin	13.18 %	10.9 %	20.19 %
Price to Book	10.97	6.41	4.36
P/E	95.0	55.31	24.77
5yr Avg Cash Conversion Cycle	38.21 Days	26.94 Days	76.63 Days
Inventory Days	87.5 Days	66.86 Days	93.94 Days
Days Receivable	85.17 Days	128.09 Days	125.3 Days
Days Payable	118.14 Days	163.91 Days	114.87 Days
5yr Average Interest Coverage Ratio	20.78	13.1	320.13
5yr Avg ROCE	17.63 %	27.25 %	51.63 %
5yr Avg Operating Profit Margin	21.01 %	18.45 %	30.06 %
5 yr average Debt to Equity	0.15	0.51	0.0
5yr CAGR Net Profit	26.4 %	14.26 %	8.5 %
5yr Average Return on Assets	9.87 %	11.52 %	15.32 %
Shareholdings
Promoter Holding	32.68 %	72.52 %	74.94 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-3.54 %	-2.48 %	-7.91 %
Change in Mutual Fund Holding (3 Yrs)	6.87 %	2.35 %	3.35 %

Business

	Neuland Laboratories	Gufic Biosciences	Alivus Life Sciences
Product Wise Break-Up	Product Wise Break-Up Formulations 59.0 Custom Manufacturing Solutions(CMS) 34.0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0 API`s 0 CDMO 0 Generic API 0 Others 7.0	Product Wise Break-Up Generic API 0 Cardiovascular 0 International 15.0 CMO 30.0 Proton pump inhibitors 0 API`s 0 Custom Manufacturing Solutions(CMS) 0 Muscle Relaxants 0 Domestic Pharmaceuticals 50.0 Anti-bacterials 0 Formulations 0 CDMO 0 Anti-fungals 0 Active Pharmaceutical Ingredient (API) 5.0	Product Wise Break-Up Generic API 24.89 Cardiovascular 0 International 0 CMO 0 Proton pump inhibitors 0 API`s 0 Custom Manufacturing Solutions(CMS) 0 Muscle Relaxants 0 Domestic 0 Anti-bacterials 0 Formulations 0 CDMO 1.82 Anti-fungals 0 API 0 Others 73.29
Location Wise Break-Up	Location Wise Break-Up India 30.39 Europe 29.86 USA 29.35 Rest of the World 10.4 South America 0 Australia 0 North America 0 Asia 0 Africa 0	Location Wise Break-Up South America 0.23 Asia Pacific 4.5 India 89.07 USA 0 Europe 3.67 North America 1.27 Rest of the World 0 Australia 0.53 Africa 0.72 Others 0.01	Location Wise Break-Up South America 0 Asia 0 India 51.09 USA 0 Europe 0 North America 0 Rest of the World 0 Australia 0 Africa 0 Others 48.91
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti-bacterial 19.72 Antidepressant 11.8 Anticonvulsant 10.46 Pain Management 0 Diabetes 0 CNS 0 CVS 0 Others 58.02	-	Therapeutic Area Break-Up CNS 14.0 CVS 42.0 Anticonvulsant 0 Diabetes 4.0 Antidepressant 0 Pain Management 4.0 Anti-bacterial 0 Others 36.0
Asset Break-Up	Asset Break-Up India 100.0	-	-

Neuland Laboratories Ltd.

SIGN UP FOR FREE